NO128157B - - Google Patents
Download PDFInfo
- Publication number
- NO128157B NO128157B NO00153787A NO15378764A NO128157B NO 128157 B NO128157 B NO 128157B NO 00153787 A NO00153787 A NO 00153787A NO 15378764 A NO15378764 A NO 15378764A NO 128157 B NO128157 B NO 128157B
- Authority
- NO
- Norway
- Prior art keywords
- solution
- water
- mixture
- hydrazine
- reaction
- Prior art date
Links
- QDHHCQZDFGDHMP-UHFFFAOYSA-N Chloramine Chemical compound ClN QDHHCQZDFGDHMP-UHFFFAOYSA-N 0.000 claims description 4
- 150000002429 hydrazines Chemical class 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 239000000203 mixture Substances 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- -1 diazides Chemical class 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 150000007857 hydrazones Chemical class 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- ALOCUZOKRULSAA-UHFFFAOYSA-N 1-methylpiperidin-4-amine Chemical compound CN1CCC(N)CC1 ALOCUZOKRULSAA-UHFFFAOYSA-N 0.000 description 1
- 229940123907 Disease modifying antirheumatic drug Drugs 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000003356 anti-rheumatic effect Effects 0.000 description 1
- 239000003435 antirheumatic agent Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 150000001470 diamides Chemical class 0.000 description 1
- 150000001990 dicarboxylic acid derivatives Chemical class 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 150000002391 heterocyclic compounds Chemical class 0.000 description 1
- OAKJQQAXSVQMHS-UHFFFAOYSA-N hydrazine Substances NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- HKOOXMFOFWEVGF-UHFFFAOYSA-N phenylhydrazine Chemical compound NNC1=CC=CC=C1 HKOOXMFOFWEVGF-UHFFFAOYSA-N 0.000 description 1
- 229940067157 phenylhydrazine Drugs 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/36—Methylene radicals, substituted by sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/02—Preparation
- C07D501/04—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
- C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB27990/63A GB1101424A (en) | 1963-07-15 | 1963-07-15 | Derivatives of 7-aminocephalosporanic acid |
| GB27989/63A GB1101423A (en) | 1963-07-15 | 1963-07-15 | Derivatives of 7-aminocephalosporanic acid |
| GB1474764 | 1964-04-09 | ||
| GB1474864 | 1964-04-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO128157B true NO128157B (de) | 1973-10-08 |
Family
ID=27448261
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO00153787A NO128157B (de) | 1963-07-15 | 1964-06-24 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US3243435A (de) |
| BE (2) | BE650445A (de) |
| BR (1) | BR6460800D0 (de) |
| CH (2) | CH469739A (de) |
| CS (1) | CS166185B2 (de) |
| DE (1) | DE1445835B2 (de) |
| DK (2) | DK124334B (de) |
| FR (2) | FR1455030A (de) |
| GB (2) | GB1101424A (de) |
| IL (2) | IL21640A (de) |
| NL (3) | NL6408067A (de) |
| NO (1) | NO128157B (de) |
| SE (1) | SE335532B (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3365449A (en) * | 1964-07-23 | 1968-01-23 | Fujisawa Pharmaceutical Co | 7-(substituted thioacylamino) cephalosporanic acid and derivatives thereof |
| US3360515A (en) * | 1964-07-24 | 1967-12-26 | Fujisawa Pharmaceutical Co | 7-(condensed n-containing heterocyclic carbonamido) cephalosporanic acid and derivatives thereof |
| US3479350A (en) * | 1966-12-05 | 1969-11-18 | Glaxo Lab Ltd | Process for the manufacture of derivatives of cephalosporin c |
| GB1277415A (en) * | 1968-06-14 | 1972-06-14 | Glaxo Lab Ltd | Improvements in or relating to cephalosporin derivatives |
| US3687948A (en) * | 1970-11-23 | 1972-08-29 | Bristol Myers Co | 7-{8 D-(a-AMINO-a-PHENYLACETAMIDO){9 -3-(4-METHYL-1,3-OXAZOL-2-YLTHIOMETHYL-3-CEPHEM-4-CARBOXYLIC ACID AND SALTS THEREOF |
| US4024135A (en) * | 1976-03-05 | 1977-05-17 | E. R. Squibb & Sons, Inc. | (Carbamoyl)pyridino derivatives of ureidocephalosporins |
| GB1565941A (en) * | 1977-02-08 | 1980-04-23 | Toyama Chemical Co Ltd | Process for producing 7-(substituted)amino-3-substituted thiomethyl cephem carboxylic acids |
| JPS6027677B2 (ja) * | 1978-07-06 | 1985-06-29 | 富山化学工業株式会社 | ７−置換又は非置換アミノ−３−置換チオメチルセフエムカルボン酸類の新規製造法 |
| US4288590A (en) * | 1980-02-14 | 1981-09-08 | Bristol-Myers Company | 7-[Dα-(4-Hydroxy-1,5-naphthyridine-3-carboxamido)-α-arylacetamido]-3-(N,N-dimethyl-aminomethylpyridinium) methyl-3-cephem-4-carboxylates |
| EP0070706B1 (de) * | 1981-07-17 | 1987-12-23 | Glaxo Group Limited | Cephalosporinverbindungen |
| WO2009049086A1 (en) | 2007-10-09 | 2009-04-16 | Larry Sutton | Broad spectrum beta-lactamase inhibitors |
| US20120329770A1 (en) * | 2010-02-26 | 2012-12-27 | Gary Igor Dmitrienko | Cephalosporin derivatives useful as beta-lactamase inhibitors and compositions and methods of use thereof |
-
0
- NL NL130098D patent/NL130098C/xx active
-
1963
- 1963-07-15 GB GB27990/63A patent/GB1101424A/en not_active Expired
- 1963-07-15 GB GB27989/63A patent/GB1101423A/en not_active Expired
-
1964
- 1964-06-24 NO NO00153787A patent/NO128157B/no unknown
- 1964-07-02 IL IL6421640A patent/IL21640A/xx unknown
- 1964-07-02 IL IL21639A patent/IL21639A/xx unknown
- 1964-07-08 FR FR981074A patent/FR1455030A/fr not_active Expired
- 1964-07-09 US US381544A patent/US3243435A/en not_active Expired - Lifetime
- 1964-07-09 US US381580A patent/US3261832A/en not_active Expired - Lifetime
- 1964-07-10 BE BE650445D patent/BE650445A/xx unknown
- 1964-07-10 BE BE650444D patent/BE650444A/xx unknown
- 1964-07-10 BR BR160800/64A patent/BR6460800D0/pt unknown
- 1964-07-10 DK DK346364AA patent/DK124334B/da unknown
- 1964-07-10 DK DK346464AA patent/DK120544C/da active
- 1964-07-13 CH CH916864A patent/CH469739A/de unknown
- 1964-07-13 CH CH916964A patent/CH469022A/de unknown
- 1964-07-14 DE DE1964G0041087 patent/DE1445835B2/de active Granted
- 1964-07-15 CS CS4101A patent/CS166185B2/cs unknown
- 1964-07-15 NL NL6408067A patent/NL6408067A/xx unknown
- 1964-07-15 SE SE08642/64A patent/SE335532B/xx unknown
- 1964-07-15 NL NL6408066A patent/NL6408066A/xx unknown
- 1964-10-06 FR FR990461A patent/FR4315M/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| GB1101423A (en) | 1968-01-31 |
| BE650445A (de) | 1965-01-11 |
| FR1455030A (fr) | 1966-04-01 |
| DK120544B (de) | 1971-06-14 |
| GB1101424A (en) | 1968-01-31 |
| NL130098C (de) | |
| BR6460800D0 (pt) | 1973-08-02 |
| CH469739A (de) | 1969-03-15 |
| DK124334B (da) | 1972-10-09 |
| DK120544C (da) | 1971-11-08 |
| BE650444A (de) | 1965-01-11 |
| SE335532B (de) | 1971-06-01 |
| US3243435A (en) | 1966-03-29 |
| IL21639A (en) | 1968-04-25 |
| CH469022A (de) | 1969-02-28 |
| NL6408067A (de) | 1965-01-18 |
| CS166185B2 (de) | 1976-01-29 |
| NL6408066A (de) | 1965-01-18 |
| FR4315M (de) | 1966-08-01 |
| DE1445835B2 (de) | 1976-04-22 |
| IL21640A (en) | 1968-04-25 |
| DE1445835A1 (de) | 1969-01-09 |
| US3261832A (en) | 1966-07-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO128157B (de) | ||
| NO119899B (de) | ||
| NO119467B (de) | ||
| NO133998B (de) | ||
| US3824255A (en) | Process for the production of tetronic acid | |
| Van Allan et al. | The reaction of some 4‐pyrones with activated isocyanates | |
| NO138978B (no) | Fremgangsmaate og apparat til strukturbehandling av kjoett, blandinger av kjoett og/eller kjoettavfall eller innmat og/eller ikke-kjoettstoffer | |
| NO116314B (de) | ||
| SU568652A1 (ru) | Способ получени три-о-ацетильного производного 1-/ - -арабинофуранозил/ цитозина или его гидрохлорида | |
| SU656511A3 (ru) | Способ получени производных гексагидро-4-индолинола или их солей | |
| NO122366B (de) | ||
| CH350650A (de) | Verfahren zur Herstellung von bisher unbekannten Hydrazin-Derivaten | |
| SU392066A1 (ru) | Способ получения изопропилгидразида 4,6-дифенилпиримидин-2-карбоновой кислоты или | |
| NO116631B (de) | ||
| SU533591A1 (ru) | Способ получени -сульфонил- замещенных мочевин | |
| SU363709A1 (ru) | Способ получения фосфорилированных | |
| US2806852A (en) | Process fgh preparing j-pyridinols | |
| SU125253A1 (ru) | Способ получени гетероциклических соединений р да пиразола, изоксазола и пирамидина | |
| SU438182A1 (ru) | Способ получени (5)-пиррилсалициловой кислоты | |
| US3159648A (en) | Process to prepare i | |
| DE875948C (de) | Verfahren zur Herstellung von diastereomeren primaeren 1, 3-Diphenyl-3-amino-propanolen-(1) | |
| SU435237A1 (ru) | Способ получения производных 5-кето-5,6,7,8-тетрагидрохинолина | |
| SU302011A1 (ru) | СПОСОБ ПОЛУЧЕНИЯ АМИНОАЦИЛЬНЫХ ПРОИЗВОДНЫХ п-АМИНОАЦЕТОФЕНОНА | |
| DE901415C (de) | Verfahren zur Herstellung von í¸-Androstadienol-(17)-on-(3) bzw. seiner funktionellen Derivate der Hydroxylgruppe | |
| SU108811A1 (ru) | Способ получени 5-нитро-4-амино-1-нафтола |